Duloxetine Capsule, Delayed Release Pellets
Product Images NDC 68788-7897

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Duloxetine (NDC 68788-7897). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Preferred Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Duloxetine Delayed Release Cap. Usp 20mg

Duloxetine Delayed Release Cap. Usp 20mg
This appears to be the label information for a medication called Duloxetine, with a warning about federal law and contents of each capsule, as well as information about the packaging and expiration date. However, there are several spelling errors and unclear formatting, making it difficult to determine specific details about the medication.*
FDA Label Image

Chemical Structure (Duloxetine 01)

Chemical Structure (Duloxetine 01)
FDA Label Image

Figure 1 (Duloxetine 02)

Figure 1 (Duloxetine 02)
FDA Label Image

Figure 2 (Duloxetine 03)

Figure 2 (Duloxetine 03)
The text describes a graph that shows the proportion of patients who experienced a relapse over time (in days) after being randomized for some type of treatment. The treatments mentioned in the text are Plocab and Duloxetine.*
FDA Label Image

Figure 3 (Duloxetine 04)

Figure 3 (Duloxetine 04)
FDA Label Image

Figure 4 (Duloxetine 05)

Figure 4 (Duloxetine 05)
FDA Label Image

Figure 5 (Duloxetine 06)

Figure 5 (Duloxetine 06)
FDA Label Image

Figure 6 (Duloxetine 07)

Figure 6 (Duloxetine 07)
FDA Label Image

Figure 8 (Duloxetine 08)

Figure 8 (Duloxetine 08)
FDA Label Image

Figure 9 (Duloxetine 09)

Figure 9 (Duloxetine 09)
This appears to be a graph displaying the percentage of patients who experienced improvement in pain after a certain treatment. The graph shows an x-axis with values ranging from 1w to b0 and a y-axis with values ranging from 20 to 100. The title of the y-axis indicates that it represents percent improvement in pain from baseline according to the BOCF method. Unfortunately, without further context or legible labels, it is not possible to determine what the treatment or condition being treated is or what the specific data points on the graph represent.*
FDA Label Image

Figure 10 (Duloxetine 10)

Figure 10 (Duloxetine 10)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.